Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberta Lock

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Nature Biomedical Engineering|April 28, 2022
Opportunities and challenges in cardiac tissue engineering from an analysis of two decades of advancesRichard Z Zhuang, Roberta Lock, Bohao Liu, et al.
Science Translational Medicine|February 11, 2021
Cell type-specific microRNA therapies for myocardial infarctionBohao Liu, Bryan Wang, Xiaokan Zhang, et al.
Frontiers in Bioengineering and Biotechnology|July 30, 2021
Human Serum Enhances Biomimicry of Engineered Tissue Models of Bone and CancerAranzazu Villasante, Samuel T Robinson, Andrew R Cohen, et al.
Nature Reviews. Materials|October 25, 2021
A framework for developing sex-specific engineered heart modelsRoberta Lock, Hadel Al Asafen, Sharon Fleischer, et al.
ACS Biomaterials Science & Engineering|October 20, 2021
milliPillar: A Platform for the Generation and Real-Time Assessment of Human Engineered Cardiac TissuesManuel Alejandro Tamargo, Trevor Ray Nash, Sharon Fleischer, et al.
Cell Reports|August 17, 2022
STK25 inhibits PKA signaling by phosphorylating PRKAR1AXiaokan Zhang, Bryan Z Wang, Michael Kim, et al.
Lab on a Chip|September 21, 2020
Integrated human organ-on-a-chip model for predictive studies of anti-tumor drug efficacy and cardiac safetyAlan Chramiec, Diogo Teles, Keith Yeager, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Nature Biomedical Engineering|April 28, 2022
Opportunities and challenges in cardiac tissue engineering from an analysis of two decades of advancesRichard Z Zhuang, Roberta Lock, Bohao Liu, et al.
Science Translational Medicine|February 11, 2021
Cell type-specific microRNA therapies for myocardial infarctionBohao Liu, Bryan Wang, Xiaokan Zhang, et al.
Frontiers in Bioengineering and Biotechnology|July 30, 2021
Human Serum Enhances Biomimicry of Engineered Tissue Models of Bone and CancerAranzazu Villasante, Samuel T Robinson, Andrew R Cohen, et al.
Nature Reviews. Materials|October 25, 2021
A framework for developing sex-specific engineered heart modelsRoberta Lock, Hadel Al Asafen, Sharon Fleischer, et al.
ACS Biomaterials Science & Engineering|October 20, 2021
milliPillar: A Platform for the Generation and Real-Time Assessment of Human Engineered Cardiac TissuesManuel Alejandro Tamargo, Trevor Ray Nash, Sharon Fleischer, et al.
Cell Reports|August 17, 2022
STK25 inhibits PKA signaling by phosphorylating PRKAR1AXiaokan Zhang, Bryan Z Wang, Michael Kim, et al.
Lab on a Chip|September 21, 2020
Integrated human organ-on-a-chip model for predictive studies of anti-tumor drug efficacy and cardiac safetyAlan Chramiec, Diogo Teles, Keith Yeager, et al.
Pageof 1